Biotech Sector ETFs Could See Big Day on GILD/VRUS Deal
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $134.28 -1.48%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
Revenue Growth %: +4.2%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
Revenue Growth %: +4.2%
Join SI Premium – FREE
Biotech stocks could see action today after Gilead Sciences (Nasdaq: GILD) to acquire Pharmasset (Nasdaq: VRUS) for $137/share.
Watch sector ETFs: iShares Nasdaq Biotechnology (NYSE: IBB), SPDR S&P Biotech (NYSE: XBI).
Watch sector ETFs: iShares Nasdaq Biotechnology (NYSE: IBB), SPDR S&P Biotech (NYSE: XBI).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Molina Healthcare to join S&P MidCap 400, Construction Partners to join S&P SmallCap 600
- Trump: I asked Darline Graham to run for U.S. senate in special Republican primary on Tuesday, August 11
- Global S&P Futures lower in premarket
Create E-mail Alert Related Categories
ETFs, Rumors, Trader TalkRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
